KaisZakhariaMD
Gastroenterology • Springfield, MAAdvanced Endoscopic Interventional, Biliary Tract Disease, Pancreas Disease
Physician
Dr. Zakharia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
759 Chestnut St
Springfield, MA 01199Phone+1 413-794-7364Fax+1 413-794-7482
Education & Training
OtherClass of 2012
Certifications & Licensure
MA State Medical License 2022 - 2025
WI State Medical License 2021 - 2023
IA State Medical License 2018 - 2022
MI State Medical License 2015 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 12 citationsBrivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling.Ikuo Nakamura, Kais Zakharia, Bubu A Banini, Dalia S Mikhail, Tae Hyo Kim
Plos One. 2014-01-01 - 28 citationsComplications, symptoms, quality of life and pregnancy in cholestatic liver disease.Kais Zakharia, Anilga Tabibian, Keith D. Lindor, James H. Tabibian
Liver International. 2018-03-01 - 36 citationsPreclinical In Vitro and In Vivo Evidence of an Antitumor Effect of CX-4945, a Casein Kinase II Inhibitor, in Cholangiocarcinoma.Kais Zakharia, Katsuyuki Miyabe, Yu Wang, Dehai Wu, Catherine D. Moser
Translational Oncology. 2019-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
